Purpose: To study the epidemiology of meibomian gland (MG) dysfunction in an elderly, predominantly male population.
M eibomian glands (MGs) are specialized sebaceous glands that secrete meibum, an essential component of the tear film. 1 Among its functions, meibum helps slow tear evaporation, protects the eye from microbes and organic particles, and preserves the clarity of the optical surface. 2 Meibomian gland dysfunction (MGD) is defined as a "chronic, diffuse abnormality of the MGs, commonly characterized by terminal duct obstruction and/or qualitative/quantitative changes in the glandular secretion." 3 Clinically, MG changes can manifest as gland atrophy, orifice obstruction, change in meibum quality, and eyelid vascularity. 3 Accompanying symptoms of MGD can range from none to severe, and MG changes can be accompanied by a variety of ocular surface findings such as decreased tear breakup time (TBUT) and corneal staining. In fact, MGD is considered the leading cause of evaporative dry eye. 3, 4 Several studies have reported on the epidemiology of MGD in the United States and worldwide (Table 1) . [5] [6] [7] The Salisbury Eye Evaluation Study evaluated individuals older than 65 years and found that 3.5% had grade 2 or higher MG plugging or collarettes. 8 In comparison, the Singapore Malay Eye Study reported a 56% MGD prevalence (defined as either MG orifice plugging or lid margin telangiectasia in at least 1 eye). 9 Other studies in Asian countries have similarly reported high prevalence estimates ranging from 39% to 68%, each using a different definition of MGD. [10] [11] [12] [13] [14] [15] In clinic-based studies and likewise using different definitions, MGD prevalence estimates range from 32% to 78% (Table 2) . [16] [17] [18] [19] [20] [21] [22] [23] [24] Risk factors for MG have also been described in the above studies and include older age, male gender, high diastolic blood pressure, and certain medications (angiotensin II receptor blockers, isotretinoin). 5 Despite this, there are still many gaps in the literature regarding the epidemiology of MGD. Most clinic-based studies had a large female population 17, 23, 25 and less has been published on MGD in men. Furthermore, associations between specific MGD parameters (eg, meibum quality versus vascularity) are missing. Our clinic at the Miami Veterans Administration Medical Center (VAMC) sees a unique patient population consisting of mostly older males, with a wide racial and ethnic distribution, and a high frequency of depression and posttraumatic stress disorder diagnoses. As such, in this study we aimed to evaluate the epidemiology of MGD in this population, including frequencies and risk factors for specific MGD parameters.
METHODOLOGY

Study Population
Patients were recruited prospectively from the VAMC eye clinic and underwent a complete ocular surface examination. Patients were excluded if they had any ocular or systemic diseases associated with dry eye including contact lenses wear; ocular medications with the exception of artificial tears; anatomic abnormality of the eyelid (eg, ectropion), conjunctivae (eg, pterygium), or cornea (eg, edema); active external ocular process; history of refractive, glaucoma, or retinal surgery; cataract surgery within the past 6 months; human immunodeficiency virus; sarcoidosis; graft-versus-host disease; Sjögren syndrome; or collagen vascular disease. The study was conducted in accordance with the principles of the Declaration of Helsinki. Miami VAMC Institutional Review Board approval was obtained to allow the prospective evaluation of patients.
Data Collected
From each participant demographic information, past ocular history, medical history, and medication information was collected. Patients filled out standardized questionnaires regarding dry eye symptoms including the dry eye questionnaire 5 26 (score 0-22) and ocular surface disease index (score 0-100). Subjects were also asked to rate the intensity of their average eye pain over a 1-week recall period using a numerical rating scale (NRS) anchored at "0," for "no pain sensation" and at "10," for "the most intense eye pain imaginable." This type of 0 to 10 NRS is recommended as the primary outcome measure in pain clinical trials. 27 Furthermore, all patients underwent tear film assessment including (1) tear osmolarity (TearLAB, San Diego, CA) (once in each eye), (2) TBUT (5 mL fluorescein placed, 3 measurements taken in each eye and averaged), as well as (3) corneal staining [National Eye Institute scale, 5 areas of cornea assessed (score 0-4 in each)], 28 Schirmer strips with anesthesia, and eyelid and MG assessment. 21 Eyelid vascularity was graded on a scale from 0 to 3 (0 = none; 1 = mild telangiectasias; 2 = moderate telangiectasias; 3 = severe telangiectasias) and meibum quality on a scale from 0 to 4 (0 = clear; 1 = cloudy; 2 = granular; 3 = toothpaste; 4 = no meibum extracted). Data were entered into a standardized database.
Main Outcome Measure
Main outcome measures were the frequency of MGD in the population and evaluation of risk factors (demographics, comorbidities) by specific MGD parameters. In this study, for both eyelid vascularity and meibum quality, we defined an abnormal parameter as a score of 2 or greater in the more severely affected eye.
Statistical Analysis
Statistical analysis was done using SPSS Statistical package 21.0. Descriptive statistics were used to summarize patient demographic and clinical information. Pearson correlations were used to evaluate the strengths of association between the above parameters.
RESULTS
Study Population
In our population of 233 patients, mean age was 63 years (SD = 11, range 27-89); 91% were male owing to the unique VAMC population. Further demographics of the study population are found in Table 3 .
Overall, 59% had at least 1 abnormal MG parameter (grade $2), with 17% (n = 39) having abnormal vascularity and 55% (n = 129) having abnormal quality. MG abnormalities were associated with one another, with 31 patients having both abnormal vascularity and quality and 86 patients having normal parameters on both measures. A total of 105 patients, on the other hand, had discordant findings: 7 abnormal vascularity only and 98 abnormal quality only (P = 0.001).
MG Parameters and Demographics and Systemic Comorbidities
Patients with abnormal eyelid vascularity and meibum quality were older than their counterparts without these findings [normal vascularity: mean 62 years (SD = 11); abnormal vascularity: mean 68 (SD = 9), P , 0.0005; normal quality: mean 61 years (SD = 11); abnormal quality: mean 64 (SD = 11), P = 0.01]. Whites were more likely to have abnormal eyelid vascularity compared with blacks (P , 0.0005) but no differences were noted between races with respect to meibum quality (P = 0.48) ( Table 3) . Patients with depression were less likely to have abnormal vascularity as were patients on an antidepressant. Patients with a diagnosis of sleep apnea, on the other hand, were more likely to have abnormal vascularity. The presence of benign prostatic hyperplasia (BPH) was associated with both abnormal vascularity and meibum quality. Those taking nonsteroidal antiinflammatory drugs (NSAIDs) were less likely to have abnormal eyelid vascularity. A multivariable model considering age and BPH found that BPH alone remained significantly associated with abnormal meibum quality [odds ratio, (OR) 3; 95% confidence interval (CI), 1.2-7.2]. A multivariable model considering all factors significantly associated with eyelid vascularity found that NSAID use and black race remained protective factors (OR, 0.2; 95% CI, 0.07-0.63; and OR, 0.02; 95% CI, 0.003-0.16; respectively) and that sleep apnea remained a risk factor (OR, 3.3; 95% CI, 1.3-8.3).
Looking at lipid levels (total cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides), no differences were seen with respect to the presence or absence of abnormal eyelid vascularity or meibum quality.
MG Parameters and Dry Eye
Abnormal meibum quality, but not abnormal vascularity, was significantly associated with dry eye symptoms and ocular pain (Table 4 ). Patients with abnormal meibum quality were also more likely to report ocular itching. Abnormal meibum quality, but not eyelid vascularity, was also significantly associated with worse dry eye signs, including decreased TBUT and increased corneal staining (Table 4 ).
DISCUSSION
We found that MGD is a frequent finding in an elderly, predominantly male population. Our frequency of 59% is within the range reported in other clinic-based studies [15] [16] [17] [18] [19] (Table 2) . Differences in MGD definition, however, make comparisons between studies difficult. Not surprisingly, we found that patients with abnormal MG parameters were older than their counterparts without these abnormalities, a finding well supported in the literature both in animal and clinical studies. 13, 29, 30 In humans without dry eye symptoms, in vivo laser scanning confocal microscopy has demonstrated atrophic, nonobstructive MG changes with age including significantly decreased acinar unit density, increased secretion reflectivity, and increased wall inhomogeneity. 31 Similarly, noncontact infrared meibography demonstrated decreased mean duct length and percent acini area and increased gland dropout in older, when compared with younger, asymptomatic individuals. 32, 33 Meibum properties also differ with age, as asymptomatic older individuals have been shown to have less CH(3) and C=C groups and higher aldehyde-to-lipid hydroperoxide ratios compared with younger individuals, as detected by H nuclear magnetic resonance spectra. 34 Histologically, MG acini of older mice have significantly reduced nuclear staining of the proliferation marker, Ki67, compared with younger mice. 29 Declining androgen levels in the aging male may underlie some of the noted changes, as similar to other sebaceous glands, the function of MGs is affected by androgen levels. 35 In our study, we also found a differential effect of race on MG parameters, with telangiectasias more frequently found in white patients, whereas abnormal meibum quality was distributed through the races. This is likely due to pigment on the eyelid margin masking our ability to detect telangiectasias and not due to a decreased frequency of MGD in blacks, given similar frequencies of abnormal meibum quality.
Prior studies have examined risk factors for MGD, with androgen deficiency, contact lens use, 36 and systemic medications (retinoic acid) all implicated. 5 This study has gone a step farther to look at systemic risk factors as they relate to specific MG abnormalities. We found that while some systemic comorbidities (eg, BPH) associated with both abnormal vascularity and meibum quality, others, such as sleep apnea, differentially associated with abnormal vascularity. In a similar manner, several systemic medications (depression, antidepressants, NSAIDs) were associated with more normal MG parameters. The significance of these associations is currently unknown. Despite a prior study which reported a positive relationship between systemic hypercholesterolemia and MGD (defined as a score of 2 or higher on either glandular obstruction or meibum quality), 37 we did not find such a relationship in our study. Interestingly, although another study also reported higher total cholesterol levels in patients with MGD (similarly defined), this difference was driven by higher high-density lipoprotein levels. In fact, patients with MGD were also found to have lower triglyceride levels compared with the general population. 38 These contradictions highlight the complex relationship between systemic lipids and sebaceous gland function.
While it is well known that some patients with MG abnormalities are asymptomatic, 13 we found a differential relationship between our measured metrics, with abnormal meibum quality associating with dry eye symptoms and ocular pain, whereas abnormal vascularity did not. In a similar manner, abnormal quality was also associated with tear film abnormalities. The lack of relationship between eyelid vascularity and dry eye symptoms and signs may be because our current physiologic testing is not sufficiently accurate to detect abnormal vessels in patients with skin pigmentation. In pigmented patients, lid margin findings may be misleadingly benign and mask underlying MGD. An alternative hypothesis is that poor meibum quality is more directly related to tear dysfunction than abnormal lid vascularity. As with all studies, our findings must be considered in light of the study limitations which include a unique patient population and specific measures of both MGD and dry eye. Despite this, our study is important because it highlights the clinical findings and relationships of MGD in an elderly male population. Also, relying on telangiectasia in the diagnosis of MGD could lead to an overestimation in white patients and underestimation in other racial groups.
In summary, MGD is a common eyelid disorder. Occurring in almost 60% of our male population, abnormal meibum quality was significantly associated with more severe dry eye symptoms, ocular pain, and worse dry eye signs, including decreased TBUT and increased corneal staining. Future identification of risk factors and comorbidities can potentially help to modulate manifestations of this disease.
